Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Chest|November 1, 2023
Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening: An Observational Study Examining the Outcomes of CHEST Expert Panel RecommendationsAndrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Nature Cancer|May 31, 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancerYin Wu, Dhruva Biswas, Ieva Usaite, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
The Lancet. Public Health|January 28, 2023
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort studyJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Gastroenterology Research and Practice|April 13, 2016
Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised TrialLesley M McGregor, Christian von Wagner, Wendy Atkin, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
BMC Cancer|August 16, 2017
Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trialSamuel G Smith, Jane Wardle, Wendy Atkin, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapySanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Chest|November 1, 2023
Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening: An Observational Study Examining the Outcomes of CHEST Expert Panel RecommendationsAndrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Nature Cancer|May 31, 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancerYin Wu, Dhruva Biswas, Ieva Usaite, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
The Lancet. Public Health|January 28, 2023
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort studyJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Gastroenterology Research and Practice|April 13, 2016
Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised TrialLesley M McGregor, Christian von Wagner, Wendy Atkin, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
BMC Cancer|August 16, 2017
Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trialSamuel G Smith, Jane Wardle, Wendy Atkin, et al.
Pageof 17